US Patent Issued to SUNSHINE LAKE PHARMA on Jan. 28 for "RET inhibitors, pharmaceutical compositions and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,085, issued on Jan. 28, was assigned to SUNSHINE LAKE PHARMA Co. LTD. (Guangdong, China).

"RET inhibitors, pharmaceutical compositions and uses thereof" was invented by Hongming Xie (Dongguan, China), Ming Luo (Dongguan, China), Jianli Wu (Dongguan, China), Yingjun Zhang (Dongguan, China) and Yingchao Cheng (Dongguan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A RET inhibitor, a pharmaceutical composition thereof and uses thereof including a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Furthermore, a pharmaceutica...